Pfenex Inc. (PFNX) financial statements (2021 and earlier)

Company profile

Business Address 10790 ROSELLE STREET
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5656588210646
Cash and cash equivalents5656588210646
Restricted cash and investments000 4 
Receivables602112
Inventory, net of allowances, customer advances and progress billings    00
Inventory    00
Other current assets222222
Other undisclosed current assets050334
Total current assets:6464628711553
Noncurrent Assets
Finance lease, right-of-use asset1
Operating lease, right-of-use asset3
Property, plant and equipment887532
Intangible assets, net (including goodwill)91010111112
Goodwill666666
Intangible assets, net (excluding goodwill)445566
Restricted cash and investments     4
Other noncurrent assets000000
Other undisclosed noncurrent assets    2 
Total noncurrent assets:211818161718
TOTAL ASSETS:85817910313271
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities812111195
Accounts payable122111
Accrued liabilities7109963
Employee-related liabilities     1
Taxes payable    2 
Deferred revenue0
Debt100 44
Deferred revenue and credits7740
Other liabilities1     
Other undisclosed current liabilities 5   (1)
Total current liabilities:10171817168
Noncurrent Liabilities
Long-term debt and lease obligation  0   
Capital lease obligations 0   
Liabilities, other than long-term debt0036443
Deferred revenue and credits3644 
Deferred tax liabilities, net    3
Other liabilities00 000
Other undisclosed noncurrent liabilities33    
Total noncurrent liabilities:3336443
Total liabilities:132022236111
Stockholders' equity
Stockholders' equity attributable to parent726158807160
Common stock000000
Additional paid in capital270262219216213173
Accumulated deficit(198)(201)(162)(136)(142)(113)
Total stockholders' equity:726158807160
TOTAL LIABILITIES AND EQUITY:85817910313271

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues501529601011
Cost of revenue(5)(5)(5)(5)(5)(7)
Gross profit:4510245553
Operating expenses(45)(50)(50)(50)(33)(13)
Operating income (loss):1(40)(26)5(28)(10)
Nonoperating income00000 
Interest and debt expense     (0)
Income (loss) from continuing operations before income taxes:1(40)(26)5(28)(10)
Income tax expense (benefit)(0) 00(0) 
Net income (loss) available to common stockholders, diluted:1(40)(26)5(28)(10)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):1(40)(26)5(28)(10)
Comprehensive income (loss), net of tax, attributable to parent:1(40)(26)5(28)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: